Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 10

Showing 10 citing articles:

Application and challenges of nitrogen heterocycles in PROTAC linker
Yang Li, Junfeng Qu, Lizhi Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116520-116520
Closed Access | Times Cited: 13
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Synthesis of α-(azidomethyl)glutarimide and its applicationin construction of potential Cereblon ligands <em>via</em> the CuAAC reaction
Liliya R Khuzhakhmetova, Anna Alekseevna Ananeva, Grigory Kantin, et al.
Mendeleev Communications (2025) Vol. 35, Iss. 1, pp. 69-72
Closed Access
Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV
Lydia S. Newton, Clara Gathmann, Sophie Ridewood, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches
Anna Bonomini, Beatrice Mercorelli, Arianna Loregian
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Recent advances in PROTAC-based antiviral and antibacterial therapeutics
Can Zhou, Shiwei Yang, Jun Wang, et al.
Bioorganic Chemistry (2025), pp. 108437-108437
Closed Access
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs
Andrea Venturi, Stefano Di Bona, Jenny Desantis, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis
Michela Eleuteri, Jenny Desantis, Gabriele Cruciani, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 17, pp. 3477-3489
Open Access
Human E3 ubiquitin ligases: accelerators and brakes for SARS-CoV-2 infection
Jesse Pellman, Anna Goldstein, Mikołaj Słabicki
Biochemical Society Transactions (2024)
Open Access
E3 ubiquitin ligase FBXO22 inhibits SARS‐CoV‐2 replication via promoting proteasome‐dependent degradation of NSP5
Yuzheng Zhou, Wei Feng, Chuwei Yang, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Closed Access
A Structural Investigation of the Interaction between a GC-376-Based Peptidomimetic PROTAC and Its Precursor with the Viral Main Protease of Coxsackievirus B3
Alessia De Santis, Deborah Grifagni, A Orsetti, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1260-1260
Open Access
Page 1

Scroll to top